»BAP Health Health participates in the I scientific conference of BiblioPRO
BAP Health team has participated at the the I scientific conference of BiblioPRO, held in Barcelona on 21st of February. BAP members signed the following papers presented at the conference:
"Validación del sistema CAT-HEALTH: el primer test adaptativo informatizado para evaluar la calidad de vida relacionada con la salud"
"Desarrollo y validación de un cuestionario genérico para la evaluación de la satisfacción de los pacientes crónicos: Cuestionario SAT-Q"
»BAP Health Health participates in the European ISPOR 2011
BAP Health team has participated at the European Congress of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), held in Berlin between 3rd-7th of November. BAP members signed the following papers presented at the conference:
"A NEW STEP IN THE USE OF COMPUTER ADAPTIVE TESTS FOR MEASURING QUALITY OF LIFE. CULTURAL ADAPTATION AND CALIBRATION IN SPAIN OF TWO PROMIS ITEM BANKS: PAIN-BEHAVIOR AND PAIN-INTERFERENCE"
"EMPLOYMENT RATES AND INDIRECT COSTS IN PATIENTS WITH END-STAGE RENAL DISEASE: DIFFERENCES BETWEEN MODALITIES OF RENAL REPLACEMENT THERAPY."
"SYSTEMATIC REVIEW OF EARLY LIFE DETERMINANTS OF METABOLIC SYNDROME AND DIABETES MELLITUS IN BANGLADESH, INDIA AND PAKISTAN"
"ASSESSING DEPRESSIVE SYMPTOMS IN PRIMARY CARE: PSYCHOMETRICAL PROPERTIES OF THE SPANISH VERSION OF THE CLINICALLY USEFUL DEPRESSION OUTCOME SCALE"
»BAP Health participates in AES.
BAP Health team has participated in the Congress of the Spanish Association of Health Economics (AES), held in Bilbao between 15 and 18 May. BAP members signed the following papers presented at the conference:
"Estimación de utilidades en pacientes con trastorno bipolar y esquizofrenia a partir de instrumentos específicos o genéricos: cuáles son las diferencias?"
"Evaluación económica de test genéticos para guiar el tratamiento en pacientes con cáncer de mama"
"Análisis coste-utilidad del retorno oportuno a diálisis tras el fallo del trasplante renal en España"
"Estudio comparativo de los costes indirectos asociados a morbilidad en pacientes con tratamiento renal sustitutivo"
»BAP Health is a partner in the GIFTS research project funded by 7th Framework Programme.
The project started in March this year. There are 16 partners from different countries of Europe and Asia. BAP participates as a SME and is in charge of a work package about economic analysis in the study.
»BAP Health Health participates in the European ISPOR 2011
BAP Health team has participated at the European Congress of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), held in Madrid between May and November 8. BAP members signed the following papers presented at the conference:
"ESTIMATING UTILITIES IN SCHIZOPHRENIC AND BIPOLAR PATIENTS FROM DISEASE-SPECIFIC OR GENERIC INSTRUMENTS ASSESSING PATIENTS' HEALTH STATES: WHERE ARE THE DIFFERENCES?"
"EVALUATING THE MANAGEMENT OF THE REHABILITATION UNIT IN A TERTIARY REFERRAL HOSPITAL IN SPAIN: A COST-ANALYSIS STUDY"
»BAP Health has joined other companies to build an international group: the ANALYTICA LA-SER OUTCOMES GROUP.
BAP Health has joined other pharma-industry service companies to build the ANALYTICA LA-SER OUTCOMES GROUP. The merged companies all have in common a high scientific background in different areas of research. The group was founded with the mission to provide the highest level of scientific evidence to optimize the real world value and health impact of medicines & health technologies.
»BAP Health is a partner in the research project "Diabetes and Pregnancy" funded by 7th Framework Programme.
The project started in March this year but has been presented recently with the Web page of the research project (www.dali-project.eu). On the website you can consult an overview of the project and its objectives and the framework and the partners involved. Form the research consortium of 12 public research centers and 2 private companies, BAP Health is one of them, from 11 European countries.